Procalcitonin: A novel cardiac marker with prognostic value in acute coronary syndrome

Journal of International Medical Research

Volumn 38, Issue 1, 2010, Pages 52-61

  Ataoǧlu, Hayriye Esra ^a   Yilmaz, F ^a   Uzunhasan, I ^b   Cetin F ^a   Temiz, L U ^a   Doventas Y E ^c   Kaya, A ^b   Yenigun M ^a  

^a Haseki Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Acute coronary syndrome; Inflammation; Procalcitonin; Prognostic marker

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROCALCITONIN; STREPTOKINASE; TROPONIN T;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; DISEASE MARKER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HORMONE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROCALCITONIN BLOOD LEVEL; PROGNOSIS; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SURVIVOR; TRANSTHORACIC ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS;

EID: 77749252563     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800106     Document Type: Article

References (31)

1. Souza JR, Oliveira RT, Blotta MH, et al: Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation. Arq Bras Cardiol 2008; 90: 86-90.
2. Massaro KS, Costa SF, Leone C, et al: Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 2007; 7: 137.
3. Yudkin JS, Stehouwer CD, Emeis JJ, et al: Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
4. Gendrel D, Bohuon C: Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679-688.
5. Maisner M: Procalcitonin - a New, Innovative Infection Parameter. Biochemical and Clinical Aspects. Stuttgart: Georg Thième, 2000.
6. Weglöhner W, Struck J, Fischer-Schulz C, et al: Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides 2001; 22: 2099-2103.
7. Birnbaum RS, Mahoney WC, Burns DM, et al: Identification of procalcitonin in a rat medullary thyroid carcinoma cell line. J Biol Chem 1984; 259: 2870-2874.
8. Jacobs JW, Lund PK, Potts JT, et al: Procalcitonin is a glycoprotein. J Biol Chem 1981; 256: 2803-2807.
9. Nishikura T: Procalcitonin (PCT) production in a thyroidectomized patient. Intensive Care Med 1999; 25: 1031.
10. Ittner L, Born W, Rau B, et al: Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma. Eur J Endocrinol 2002; 147: 727-731.
11. Meisner M, Müller V, Khakpour Z, et al: Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 2003; 19: 187-190.
12. Ridker PM: Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 2007; 65: S253-S259.
13. Yarnell JW, Baker IA, Sweetnam PM, et al: Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844.
14. Sentürk T, Cordan J, Baran I, et al: Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 2007; 62: 135-141.
15. Maruna P, Nedelnikova K, Gürlich R: Physiology and genetics of procalcitonin. Physiol Res 2000; 49(suppl 1): S57-S61.
16. Hatherill M, Tibby SM, Turner C, et al: Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000; 28: 2591-2594.
17. Clec'h C, Fosse JP, Karoubi P, et al: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006; 34: 102-107.
18. Meisner M, Rauschmayer C, Schmidt J, et al: Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002; 28: 1094-1102.
19. Lang RM, Bierig M, Devereux RB, et al: Recommendations for Chamber Quantification: a Report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiography 2005; 18: 1440-1463.
20. Meisner M, Adina H, Schmidt J: Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006; 10: R1.
21. Fries M, Kunz D, Gressner AM, et al: Procalcitonin serum levels after out-of-hospital cardiac arrest. Resuscitation 2003; 59: 105-109.
22. Christ-Crain M, Muller B: Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly 2005; 135: 451-460.
23. Cosin-Sales J, Kaski JC, Christiansen M, et al: Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 2005; 26: 2093-2098.
24. Hamm CW, Goldmann BU, Heeschen C, et al: Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-1653.
25. Antman EM, Tanasijevic MJ, Thompson B, et al: Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-1349.
26. Hamm CW, Ravkilde J, Gerhardt W, et al: The prognostic value of serumtroponin T in unstable angina. N Engl J Med 1992; 327: 146-150.
27. Lee CC, Chen SY, Tsai CL, et al: Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008; 29: 322-327.
28. Jensen JU, Heslet L, Jensen TH, et al: Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34: 2596-2602.
29. Erren M, Reinecke H, Junker R, et al: Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-2363.
30. Remskar M, Horvat M, Hojker S, et al: Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 2002; 114: 205-210.
31. Dandona P, Nix D, Wilson MF, et al: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-1608.